Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin infusion administration methods for blood loss prevention at caesarean section
PACTR201909775190644Completed
- Sponsor
- Aduloju Olusola Peter
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Aduloju Olusola Peter. Primary endpoint: Blood loss during caesarean section. Started Feb 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR201909775190644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909775190644.